The outcome of macroprolactinomas resistant to dopamine agonists
Aim: The present study aims to assess the final outcome after combined therapeutic approaches in patients with macroprolactinoinas resistant to dopamine agonists (DA). Patients: Records of patients with macroprolactinoma hospitalized in the Institute of Endocrinology, Bucharest, between 1978-2005, w...
主要な著者: | Coculescu, M, Anghel, R, Trifanescu, R, Voicu, D, Karavitaki, N, Wass, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2005
|
類似資料
-
Macroprolactinoma resistente aos agonistas dopaminérgicos: relato de caso Macroprolactinoma resistant to dopamine agonists: a case report
著者:: Rosana Maria dos Reis, 等
出版事項: (2004-09-01) -
Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
著者:: Barber, T, 等
出版事項: (2011) -
Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
著者:: Karavitaki, N, 等
出版事項: (2010) -
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature
著者:: Eng-Loon Tng, 等
出版事項: (2023-03-01) -
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
著者:: Karavitaki, N, 等
出版事項: (2013)